{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T02:11:20Z","timestamp":1767665480487},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1053\/j.semnephrol.2003.08.010","type":"journal-article","created":{"date-parts":[[2004,1,16]],"date-time":"2004-01-16T20:45:36Z","timestamp":1074285936000},"page":"25-38","source":"Crossref","is-referenced-by-count":30,"title":["Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy"],"prefix":"10.1016","volume":"24","author":[{"given":"Keith A","family":"Hruska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Saab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lala R","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl O","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kameswaran","family":"Surendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnephrol.2003.08.010_BIB1","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1359\/jbmr.2002.17.12.2094","article-title":"Pathophysiology and recent advances in the management of renal osteodystrophy","volume":"17","author":"Elder","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/snep.2002.35965","article-title":"Renal osteodystrophy in chronic renal failure","volume":"22","author":"Ho","year":"2002","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB3","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB4","doi-asserted-by":"crossref","unstructured":"Lund RJ, Davies MR, Brown AJ, et al: Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model. J Am Soc Nephrol (in press)","DOI":"10.1097\/01.ASN.0000109671.99498.08"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s004670000364","article-title":"Bone morphogenetic proteins and skeletal development","volume":"14","author":"Reddi","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1530\/eje.0.1420009","article-title":"Bone morphogenetic proteins in human bone regeneration","volume":"142","author":"Groeneveld","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S8756-3282(99)00113-1","article-title":"Signal transduction by bone morphogenetic protein receptors","volume":"25","author":"Miyazono","year":"1999","journal-title":"Bone"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1359-6101(99)00025-8","article-title":"TGF-\u03b2 signaling by Smad proteins","volume":"11","author":"Miyazono","year":"2000","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/bbrc.1996.0411","article-title":"Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2\/PA6","volume":"220","author":"Yamaguchi","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB10","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1210\/en.136.6.2671","article-title":"The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro","volume":"136","author":"Hughes","year":"1995","journal-title":"Endocrinology"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB11","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1242\/jcs.112.20.3519","article-title":"Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation","volume":"112","author":"Ebisawa","year":"1999","journal-title":"J Cell Sci"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB12","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.0.CO;2-B","article-title":"Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2","volume":"67","author":"Lecanda","year":"1997","journal-title":"J Cell Biochem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB13","doi-asserted-by":"crossref","first-page":"20352","DOI":"10.1016\/S0021-9258(19)88709-4","article-title":"Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro","volume":"267","author":"Sampath","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB14","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1006\/cyto.2000.0760","article-title":"Stimulatory effects of cartilage-derived morphogenetic proteins 1 and 2 on osteogenic differentiation of bone marrow stromal cells","volume":"12","author":"Gruber","year":"2000","journal-title":"Cytokine"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB15","unstructured":"Chaudhary LR, Hofmeister AM, Hruska KA: Differential growth factor regulation of bone formation by human osteoprogenitor cells in vivo. Bone (in press)"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1432-0436.1995.5820157.x","article-title":"Osteogenin (bone morphogenic protein 3) inhibits proliferation and stimulates differentiation of osteoprogenitors in human bone marrow","volume":"58","author":"Amedee","year":"1994","journal-title":"Differentiation"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB17","doi-asserted-by":"crossref","DOI":"10.2106\/00004623-200100001-00008","article-title":"BMP3","volume":"83","author":"Bahamonde","year":"2001","journal-title":"J Bone Joint Surg"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1006\/bbrc.1997.7792","article-title":"Opposing actions of BMP3 and TGF\u03b21 in human bone marrow stromal cell growth and differentiation","volume":"241","author":"Faucheux","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1006\/mthe.2002.0691","article-title":"Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer","volume":"6","author":"Jane","year":"2002","journal-title":"Mol Ther"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB20","first-page":"587","article-title":"Bone morphogenetic protein gene therapy","volume":"27","author":"Alden","year":"2003","journal-title":"Spine"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB21","doi-asserted-by":"crossref","unstructured":"Nochi H, Sung JH, Lou J, et al: Adenovirus mediated BMP-13 gene transfer induces chondrogenic differentiation of murine mesenchymal progenitor cells. J Bone Miner Res (in press)","DOI":"10.1359\/jbmr.2004.19.1.111"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB22","first-page":"F382","article-title":"Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney","volume":"276","author":"Simon","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB23","first-page":"655A","article-title":"Loss of renal tubular BMP7 during the evolution of experimental diabetic nephropathy","volume":"11","author":"Wang","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s004670000341","article-title":"Pathophysiology of renal osteodystrophy","volume":"14","author":"Hruska","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB25","series-title":"Renal Osteodystrophy, Philadelphia","first-page":"221","article-title":"Growth factors and cytokines in renal osteodystrophy","author":"Hruska","year":"1998"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/8756-3282(94)90322-0","article-title":"Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow","volume":"15","author":"Nishida","year":"1994","journal-title":"Bone"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB27","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/jbmr.5650111003","article-title":"Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages","volume":"11","author":"Isogai","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1097-4644(20000401)77:1<149::AID-JCB15>3.0.CO;2-N","article-title":"Parathyroid hormone inhibits collagen synthesis and the activity of rat Collal transgenes mainly by a cAMP-mediated pathway in mouse calvariae","volume":"77","author":"Bogdanovic","year":"2000","journal-title":"J Cell Biochem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1006807221545","article-title":"Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells","volume":"178","author":"Chaudhary","year":"1998","journal-title":"Mol Cell Biochem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB30","first-page":"477","article-title":"Comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1\u201334) on rat bone","volume":"16","author":"Uzawa","year":"1995","journal-title":"Bone"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB31","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1046\/j.1523-1755.2002.00258.x","article-title":"Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7","volume":"61","author":"Gonzalez","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB32","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1101\/gad.9.22.2808","article-title":"BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning","volume":"9","author":"Luo","year":"1995","journal-title":"Genes Dev"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB33","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1159\/000066649","article-title":"Organization of bone morphogenetic proteins in renal development","volume":"93","author":"Martinez","year":"2003","journal-title":"Nephron Exp Nephrol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB34","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1101\/gad.9.22.2795","article-title":"A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye","volume":"9","author":"Dudley","year":"1995","journal-title":"Genes Dev"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/(SICI)1097-4652(199912)181:3<410::AID-JCP4>3.0.CO;2-H","article-title":"Expression of osteogenic protein-1 mRNA in cultured kidney cells","volume":"181","author":"Kitten","year":"1999","journal-title":"J Cell Physiol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1172\/JCI2237","article-title":"Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat","volume":"102","author":"Vukicevic","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB37","first-page":"F130","article-title":"Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction","volume":"279","author":"Hruska","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB38","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1681\/ASN.V13suppl_1s14","article-title":"Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function","volume":"13","author":"Morrissey","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB39","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1046\/j.1523-1755.2003.00035.x","article-title":"Bone morphogenetic protein-7 (BMP-7), a novel therapy for diabetic nephropathy","volume":"63","author":"Wang","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB40","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/nm888","article-title":"BMP-7 counteracts TGF\u03b21-induced epithelial-to-mesenchymal transition and reverses chronic renal injury","volume":"9","author":"Zeisberg","year":"2003","journal-title":"Nature Med"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1523-1755.2001.060002472.x","article-title":"Pathophysiological mechanisms of vascular calcification in end-stage renal disease","volume":"60","author":"Davies","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO;2-M","article-title":"Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro","volume":"184","author":"Dorai","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB43","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/01.ASN.0000068404.57780.DD","article-title":"BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure","volume":"14","author":"Davies","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","article-title":"The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption","volume":"15","author":"Hofbauer","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB46","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.192.4.463","article-title":"Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis","volume":"192","author":"Min","year":"2000","journal-title":"J Exp Med"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9440(10)64556-7","article-title":"Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo","volume":"157","author":"Lacey","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB49","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1083\/jcb.145.3.527","article-title":"The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts","volume":"145","author":"Burgess","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB50","first-page":"27","article-title":"Plasma proteins in human cortical bone","volume":"22","author":"Triffitt","year":"1976","journal-title":"Calcif Tissue Int"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/03008208509089845","article-title":"Changes with age in the non-collagenous proteins of human bone","volume":"14","author":"Dickson","year":"1985","journal-title":"Connect Tissue Res"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF02405000","article-title":"Variations in the serum concentration and urine excretion of alpha 2HS-glycoprotein, a bone related protein, in normal individuals and in patients with osteogenesis imperfecta","volume":"35","author":"Dickson","year":"1983","journal-title":"Calcif Tissue Int"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF02405363","article-title":"Noncollagenous proteins in normal and pathological human bone","volume":"36","author":"Quelch","year":"1984","journal-title":"Calcif Tissue Int"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB54","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/cs0580435","article-title":"Plasma alpha 2HS-glycoprotein concentration in Paget\u2019s disease of bone","volume":"58","author":"Ashton","year":"1980","journal-title":"Clin Sci"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB55","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/pgmj.59.691.304","article-title":"Alpha 2HS-glycoprotein in the serum and urine of patients with renal diseases","volume":"59","author":"Kishore","year":"1983","journal-title":"Postgrad Med"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB56","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","article-title":"Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis","volume":"361","author":"Ketteler","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/jcem-66-1-187","article-title":"Human serum alpha 2HS-glycoprotein modulates in vitro bone resorption","volume":"66","author":"Colclasure","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1083\/jcb.92.1.227","article-title":"Recruit of osteoclast precursors by purified bone matrix constituents","volume":"92","author":"Malone","year":"1982","journal-title":"J Cell Biol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB59","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jcp.1041320116","article-title":"Alpha 2HS glycoprotein is chemotactic for mononuclear phagocytes","volume":"132","author":"Malone","year":"1987","journal-title":"J Cell Physiol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB60","first-page":"481","article-title":"Enhancement of human monocyte phagocytic function by alpha 2HS glycoprotein","volume":"42","author":"Lewis","year":"1981","journal-title":"Immunology"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0167-4838(89)90293-8","article-title":"The position of the disulfide bonds in human plasma alpha 2HS-glycoprotein and the repeating double disulfide bonds in the domain structure","volume":"994","author":"Araki","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-5793(87)80010-8","article-title":"Fetuin","volume":"214","author":"Christie","year":"1987","journal-title":"FEBS Lett"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB63","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1016\/S0021-9258(19)39571-7","article-title":"The complete cDNA and amino acid sequence of bovine fetuin","volume":"265","author":"Dziegielewska","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB64","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-5793(88)80890-1","article-title":"Cystatin domains in alpha-2-HS glycoprotein and fetuin","volume":"227","author":"Elzanowski","year":"1988","journal-title":"FEBS Lett"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB65","doi-asserted-by":"crossref","first-page":"14121","DOI":"10.1016\/S0021-9258(18)71651-7","article-title":"The arrangement of disulfide loops in human alpha2-HS glycoprotein","volume":"264","author":"Kellerman","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB66","doi-asserted-by":"crossref","first-page":"20789","DOI":"10.1074\/jbc.271.34.20789","article-title":"The serum protein alpha2-HS glycoprotein\/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells","volume":"271","author":"Schinke","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB67","doi-asserted-by":"crossref","first-page":"12755","DOI":"10.1074\/jbc.271.22.12755","article-title":"Fetuin\/alpha2-HS glycoprotein is transforming growth factor-beta type II receptor mimic and cytokine antagonist","volume":"271","author":"Demetriou","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB68","doi-asserted-by":"crossref","first-page":"28514","DOI":"10.1074\/jbc.274.40.28514","article-title":"Regulation of osteogenesis by Fetuin","volume":"274","author":"Binkert","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB69","doi-asserted-by":"crossref","first-page":"31496","DOI":"10.1074\/jbc.272.50.31496","article-title":"Cloning and targeted deletion of the mouse fetuin gene","volume":"272","author":"Jahnen-Dechent","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB70","doi-asserted-by":"crossref","first-page":"19991","DOI":"10.1074\/jbc.M112234200","article-title":"Alpha2-HS glycoprotein\/fetuin, a transforming growth factor-beta\/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling","volume":"277","author":"Szweras","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB71","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0014-5793(02)02872-7","article-title":"PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways","volume":"521","author":"Zhang","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB72","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein","volume":"386","author":"Luo","year":"1997","journal-title":"Nature"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB73","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/hq1001.097102","article-title":"Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D","volume":"21","author":"Price","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB74","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/01.RES.0000033987.22436.50","article-title":"SB 242784, a selective inhibitor of the osteoclastic V-H+-ATPase, inhibits arterial calcification in the rat","volume":"91","author":"Price","year":"2002","journal-title":"Circ Res"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB75","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.100.21.2168","article-title":"Medial localization of mineralization-regulating proteins in association with monckeberg\u2019s sclerosis","volume":"100","author":"Shanahan","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB76","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1161\/01.ATV.18.3.379","article-title":"Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression","volume":"18","author":"Proudfoot","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB77","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.ATV.0000059406.92165.31","article-title":"Osteo\/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification","volume":"23","author":"Tyson","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB78","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1161\/hq1201.100229","article-title":"Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques","volume":"21","author":"Dhore","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB79","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/jc.86.2.631","article-title":"Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women","volume":"86","author":"Browner","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB80","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.0000031524.49139.29","article-title":"Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease","volume":"106","author":"Jono","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB81","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1210\/jc.2002-020775","article-title":"Increased osteoprotegerin serum levels in men with coronary artery disease","volume":"88","author":"Schoppet","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB82","doi-asserted-by":"crossref","first-page":"76e","DOI":"10.1161\/01.CIR.0000060815.25798.02","article-title":"Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men","volume":"107","author":"Schoppet","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB83","first-page":"L1045","article-title":"TRAIL expression in vascular smooth muscle","volume":"278","author":"Gochuico","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB84","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL","volume":"273","author":"Emery","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB85","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0006-291X(02)00533-8","article-title":"Activation of peroxisome-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells","volume":"294","author":"Fu","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB86","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.RES.0000029080.15742.85","article-title":"Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy","volume":"91","author":"Bishop-Bailey","year":"2002","journal-title":"Circ Res"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB87","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI118991","article-title":"Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia","volume":"98","author":"Law","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB88","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1074\/jbc.M106366200","article-title":"Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix Gla protein in the serum of etidronate-treated rats","volume":"277","author":"Price","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB89","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1359\/jbmr.2002.17.7.1171","article-title":"Bone origin of the serum complex of calcium, phosphate, and matrix gla protein","volume":"17","author":"Price","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB90","doi-asserted-by":"crossref","first-page":"22153","DOI":"10.1074\/jbc.M300739200","article-title":"Biochemical characterization of the serum fetuin-mineral complex","volume":"278","author":"Price","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB91","doi-asserted-by":"crossref","first-page":"22144","DOI":"10.1074\/jbc.M300744200","article-title":"The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex","volume":"278","author":"Price","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB92","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1074\/jbc.M210868200","article-title":"Structural basis of calcification inhibition by \u03b12-HS glycoprotein\/Fetuin-A","volume":"278","author":"Heiss","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB93","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0021-9150(85)90166-2","article-title":"Identification and quantification of alpha 2-HS glycoprotein in the mineralized matrix of calcified plaques of atherosclerotic human aorta","volume":"55","author":"Keeley","year":"1985","journal-title":"Atherosclerosis"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB94","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0009-8981(02)00013-X","article-title":"Plasma alpha2-HS glycoprotein concentrations in patients with acute myocardial infarction quantified by a modified ELISA","volume":"319","author":"Mathews","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB95","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1172\/JCI109551","article-title":"Serum concentration of human alpha 2-HS glycoprotein during the inflammatory process","volume":"64","author":"Lebreton","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB96","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-5793(88)81059-7","article-title":"The synthesis of alpha-2-HS glycoprotein is down-regulated by cytokines in hepatoma HepG2 cells","volume":"241","author":"Daveau","year":"1988","journal-title":"FEBS Lett"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB97","first-page":"1019","article-title":"Increased levels of osteoprotegerin in hemodialysis patients","volume":"40","author":"Avbersek-Luznik","year":"2002","journal-title":"Clin Chem"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB98","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/ajkd.2002.31402","article-title":"Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure","volume":"39","author":"Kazama","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB99","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/ajkd.2002.31409","article-title":"Osteoprotegrin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients","volume":"39","author":"Haas","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.semnephrol.2003.08.010_BIB100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ndt\/17.2.233","article-title":"Serum osteoprotegerin and renal osteodystrophy","volume":"17","author":"Coen","year":"2002","journal-title":"Nephrol Dial Transplant"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929503001396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929503001396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T01:02:39Z","timestamp":1623632559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929503001396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0270929503001396"],"URL":"https:\/\/doi.org\/10.1053\/j.semnephrol.2003.08.010","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}